Kolexia
Harbi Samia Hématologie
Harbi Samia
Hématologie
Centre Paoli-Calmettes
Marseille, France
118 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Lymphomes Leucémies Leucémie aigüe myéloïde Tumeurs hématologiques Leucémie myéloïde Maladie de Hodgkin Maladie chronique Maladie aigüe

Collaborateurs

Voir plus
Blaise Didier
Blaise Didier
Centre Paoli-Calmettes, Marseille, France
Furst Sabine
Furst Sabine
Centre Paoli-Calmettes, Marseille, France
Devillier Raynier
Devillier Raynier
Centre Paoli-Calmettes, Marseille, France
Chabannon Christian
Chabannon Christian
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2023
B3TSI
2 collaboration(s)
Dernière en 2021
Sanofi
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
A Single Center Real World Experience of Allogeneic HSCT of Patients with MDS/CMML in Aged Population
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Cancer chemotherapy and pharmacology   13 novembre 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Bone marrow transplantation   03 novembre 2023
Allogeneic Hematopoietic Cell Transplantation in the Elderly Results in Similar Survival with Matched Related or Unrelated and Haploidentical Donors: A Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)
65th ASH Annual Meeting Abstracts   02 novembre 2023
POSTER: AML-110 Outcome of Acute Myeloid Leukemia Relapse After Allogenic Stem Cell Transplantation: A Single-Institution Retrospective Study
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
AML-110 Outcome of Acute Myeloid Leukemia Relapse After Allogenic Stem Cell Transplantation: A Single-Institution Retrospective Study
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Bone marrow transplantation   09 août 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation   29 juin 2023
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Bone marrow transplantation   30 décembre 2022
Prep@Gref: Software Streamlining for the Search for Donors for Hematopoietic Stem Cell Transplantation
Annual Meeting Abstracts 2022   15 novembre 2022